Novel Therapies for the Treatment of Inflammatory Bowel Disease

Dear Colleagues,

It is well known that inflammatory bowel disease can be a heterogenous condition with great diversity in presentation, disease course, and response to treatment. For patients that have a poor treatment response or experience adverse events relating to certain drug regimens, novel efficacious therapies may be utilised to provide symptom relief and reduce disease activity. Novel therapies include emerging treatments that are still in the experimental stage, newly approved therapies, treatments that have been effective in other inflammatory conditions and have a role in IBD, and isolated therapies that have been successfully implemented for certain individuals.

We invite papers that report quantified outcomes on the implementation of novel therapies and welcome original studies, systematic reviews and meta-analyses, case-reports, and scoping reviews.

Dr. Angharad Vernon-Roberts
Prof. Dr. Andrew Day
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastrointestinal Disorders is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.